Zoetis Inc Stock Price To Sales

ZTS Stock

USD 175.25 1.49 0.84%

Zoetis Inc fundamentals help investors to digest information that contributes to Zoetis' financial success or failures. It also enables traders to predict the movement of Zoetis Stock. The fundamental analysis module provides a way to measure Zoetis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zoetis stock.

		Last Reported	Projected for Next Year
	Price To Sales Ratio	10.65	5.59

Price To Sales Ratio is likely to drop to 5.59 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Zoetis Inc Company Price To Sales Analysis

Zoetis' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current Zoetis Price To Sales

8.71 X

Most of Zoetis' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zoetis Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Zoetis Price To Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for Zoetis is extremely important. It helps to project a fair market value of Zoetis Stock properly, considering its historical fundamentals such as Price To Sales. Since Zoetis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Zoetis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Zoetis' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant Equipment	Retained Earnings	Deferred Long Term Liab	Treasury Stock	Common Stock	Net Tangible Assets	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Cash And Equivalents	Net Invested Capital	Net Working Capital	Long Term Investments	Capital Stock
Total Assets		0.56	-0.07	0.73	0.6	0.87	0.78	0.97	0.92	0.98	-0.06	0.7	0.94	0.86	0.57	-0.91	-0.24	0.23	-0.71	0.94	0.67	0.95	0.94	0.8	0.9	-0.24
Total Stockholder Equity	0.56		-0.33	-0.11	0.23	0.1	0.32	0.51	0.19	0.52	-0.32	0.2	0.68	0.6	-0.05	-0.63	-0.25	0.6	-0.34	0.63	0.59	0.7	0.68	0.68	0.68	-0.25
Current Deferred Revenue	-0.07	-0.33		0.09	0.01	0.04	-0.21	-0.04	0.07	-0.06	-0.23	0.07	-0.19	-0.28	0.12	0.29	0.3	-0.39	-0.21	-0.19	-0.29	-0.16	-0.17	-0.25	0.04	0.3
Net Debt	0.73	-0.11	0.09		0.43	0.94	0.71	0.76	0.91	0.68	0.19	0.71	0.61	0.57	0.71	-0.61	-0.18	-0.26	-0.61	0.65	0.44	0.55	0.56	0.32	0.53	-0.18
Accounts Payable	0.6	0.23	0.01	0.43		0.56	0.75	0.49	0.6	0.67	-0.28	0.19	0.58	0.52	0.11	-0.52	-0.19	0.4	-0.41	0.55	0.44	0.62	0.61	0.64	0.57	-0.19
Long Term Debt	0.87	0.1	0.04	0.94	0.56		0.75	0.88	0.99	0.86	0.14	0.75	0.74	0.69	0.75	-0.72	-0.17	-0.08	-0.64	0.79	0.49	0.74	0.72	0.57	0.68	-0.17
Net Receivables	0.78	0.32	-0.21	0.71	0.75	0.75		0.7	0.77	0.79	-0.14	0.37	0.83	0.79	0.27	-0.81	-0.42	0.37	-0.56	0.77	0.75	0.76	0.76	0.63	0.73	-0.42
Good Will	0.97	0.51	-0.04	0.76	0.49	0.88	0.7		0.91	0.9	-0.07	0.85	0.87	0.81	0.7	-0.85	-0.21	0.04	-0.77	0.94	0.61	0.88	0.88	0.69	0.86	-0.21
Total Liab	0.92	0.19	0.07	0.91	0.6	0.99	0.77	0.91		0.91	0.08	0.74	0.79	0.73	0.7	-0.78	-0.17	-0.01	-0.68	0.82	0.52	0.8	0.79	0.62	0.75	-0.17
Total Current Assets	0.98	0.52	-0.06	0.68	0.67	0.86	0.79	0.9	0.91		-0.03	0.58	0.91	0.83	0.49	-0.88	-0.2	0.34	-0.62	0.87	0.62	0.94	0.92	0.84	0.87	-0.2
Short Term Debt	-0.06	-0.32	-0.23	0.19	-0.28	0.14	-0.14	-0.07	0.08	-0.03		0.04	-0.13	-0.14	0.29	0.11	0.2	-0.23	0.51	-0.21	-0.2	-0.12	-0.23	-0.21	-0.21	0.2
Intangible Assets	0.7	0.2	0.07	0.71	0.19	0.75	0.37	0.85	0.74	0.58	0.04		0.49	0.51	0.91	-0.55	-0.1	-0.43	-0.7	0.72	0.27	0.55	0.57	0.31	0.53	-0.1
Property Plant Equipment	0.94	0.68	-0.19	0.61	0.58	0.74	0.83	0.87	0.79	0.91	-0.13	0.49		0.87	0.31	-0.91	-0.31	0.43	-0.62	0.91	0.82	0.95	0.92	0.8	0.92	-0.31
Retained Earnings	0.86	0.6	-0.28	0.57	0.52	0.69	0.79	0.81	0.73	0.83	-0.14	0.51	0.87		0.39	-0.98	-0.68	0.49	-0.7	0.9	0.87	0.91	0.95	0.83	0.84	-0.68
Deferred Long Term Liab	0.57	-0.05	0.12	0.71	0.11	0.75	0.27	0.7	0.7	0.49	0.29	0.91	0.31	0.39		-0.4	-0.09	-0.5	-0.53	0.54	0.14	0.41	0.39	0.22	0.36	-0.09
Treasury Stock	-0.91	-0.63	0.29	-0.61	-0.52	-0.72	-0.81	-0.85	-0.78	-0.88	0.11	-0.55	-0.91	-0.98	-0.4		0.56	-0.45	0.68	-0.91	-0.82	-0.92	-0.97	-0.81	-0.87	0.56
Common Stock	-0.24	-0.25	0.3	-0.18	-0.19	-0.17	-0.42	-0.21	-0.17	-0.2	0.2	-0.1	-0.31	-0.68	-0.09	0.56		-0.44	0.44	-0.43	-0.73	-0.37	-0.46	-0.42	-0.31	1.0
Net Tangible Assets	0.23	0.6	-0.39	-0.26	0.4	-0.08	0.37	0.04	-0.01	0.34	-0.23	-0.43	0.43	0.49	-0.5	-0.45	-0.44		0.04	0.25	0.52	0.46	0.46	0.66	0.41	-0.44
Short Long Term Debt	-0.71	-0.34	-0.21	-0.61	-0.41	-0.64	-0.56	-0.77	-0.68	-0.62	0.51	-0.7	-0.62	-0.7	-0.53	0.68	0.44	0.04		-0.77	-0.59	-0.64	-0.73	-0.52	-0.65	0.44
Long Term Debt Total	0.94	0.63	-0.19	0.65	0.55	0.79	0.77	0.94	0.82	0.87	-0.21	0.72	0.91	0.9	0.54	-0.91	-0.43	0.25	-0.77		0.79	0.94	0.93	0.78	0.86	-0.43
Capital Surpluse	0.67	0.59	-0.29	0.44	0.44	0.49	0.75	0.61	0.52	0.62	-0.2	0.27	0.82	0.87	0.14	-0.82	-0.73	0.52	-0.59	0.79		0.78	0.77	0.69	0.73	-0.73
Cash And Equivalents	0.95	0.7	-0.16	0.55	0.62	0.74	0.76	0.88	0.8	0.94	-0.12	0.55	0.95	0.91	0.41	-0.92	-0.37	0.46	-0.64	0.94	0.78		0.96	0.89	0.93	-0.37
Net Invested Capital	0.94	0.68	-0.17	0.56	0.61	0.72	0.76	0.88	0.79	0.92	-0.23	0.57	0.92	0.95	0.39	-0.97	-0.46	0.46	-0.73	0.93	0.77	0.96		0.88	0.91	-0.46
Net Working Capital	0.8	0.68	-0.25	0.32	0.64	0.57	0.63	0.69	0.62	0.84	-0.21	0.31	0.8	0.83	0.22	-0.81	-0.42	0.66	-0.52	0.78	0.69	0.89	0.88		0.78	-0.42
Long Term Investments	0.9	0.68	0.04	0.53	0.57	0.68	0.73	0.86	0.75	0.87	-0.21	0.53	0.92	0.84	0.36	-0.87	-0.31	0.41	-0.65	0.86	0.73	0.93	0.91	0.78		-0.31
Capital Stock	-0.24	-0.25	0.3	-0.18	-0.19	-0.17	-0.42	-0.21	-0.17	-0.2	0.2	-0.1	-0.31	-0.68	-0.09	0.56	1.0	-0.44	0.44	-0.43	-0.73	-0.37	-0.46	-0.42	-0.31

Click cells to compare fundamentals

Zoetis Price To Sales Historical Pattern

Today, most investors in Zoetis Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Zoetis' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Zoetis price to sales as a starting point in their analysis.

Zoetis Price To Sales

Timeline

The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Competition

Predict Zoetis

Price To Sales Ratio Over Time

Zoetis Price To Sales Ratio

Price To Sales Ratio

5.59

At this time, Zoetis' Price To Sales Ratio is comparatively stable compared to the past year.

Based on the latest financial disclosure, Zoetis Inc has a Price To Sales of 8.7127 times. This is 59.29% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 23.71% higher than that of the company.

Zoetis Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zoetis' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zoetis could also be used in its relative valuation, which is a method of valuing Zoetis by comparing valuation metrics of similar companies.

Zoetis is currently under evaluation in price to sales category among its peers.

Zoetis ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Zoetis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Zoetis' managers, analysts, and investors.

Environmental

Governance

Social

Zoetis Fundamentals

	Return On Equity	0.47
	Return On Asset	0.15
	Profit Margin	0.27 %
	Operating Margin	0.39 %
	Current Valuation	84.11 B
	Shares Outstanding	451.16 M
	Shares Owned By Insiders	0.20 %
	Shares Owned By Institutions	95.74 %
	Number Of Shares Shorted	4.69 M
	Price To Earning	43.89 X
	Price To Book	15.11 X
	Price To Sales	8.71 X
	Revenue	8.54 B
	Gross Profit	5.63 B
	EBITDA	3.69 B
	Net Income	2.34 B
	Cash And Equivalents	3.58 B
	Cash Per Share	5.88 X
	Total Debt	6.75 B
	Debt To Equity	1.48 %
	Current Ratio	2.18 X
	Book Value Per Share	11.59 X
	Cash Flow From Operations	2.35 B
	Short Ratio	1.83 X
	Earnings Per Share	5.33 X
	Price To Earnings To Growth	2.44 X
	Target Price	214.78
	Number Of Employees	14.1 K
	Beta	0.9
	Market Capitalization	79.74 B
	Total Asset	14.29 B
	Retained Earnings	10.29 B
	Working Capital	4.45 B
	Current Asset	3.83 B
	Current Liabilities	1.78 B
	Annual Yield	0.01 %
	Five Year Return	0.55 %
	Net Asset	14.29 B
	Last Dividend Paid	1.67

About Zoetis Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Zoetis Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zoetis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zoetis Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Zoetis Stock Analysis

When running Zoetis' price analysis, check to measure Zoetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zoetis is operating at the current time. Most of Zoetis' value examination focuses on studying past and present price action to predict the probability of Zoetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zoetis' price. Additionally, you may evaluate how the addition of Zoetis to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC